Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acta Pharmaceuticals closes $24 million in Seed financing to advance its Alzheimer’s disease pipeline focused on early intervention and prevention.
Amount Raised
$24 Million
Round Type
Seed
Description
Acta Pharmaceuticals has successfully closed a $24 million Seed financing round. The funding will support their Alzheimer’s disease pipeline, specifically targeting early intervention and prevention strategies. Additionally, the company will commence a phase 1 study for GSM-779690T. This financing marks a significant step in Acta's ongoing research efforts.
Fundz sees it the moment Acta Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Acta Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.